,outcome,arm 1,arm 2
0,intervention,pioglitazone,glimepirede
0,"intent-to-treat, HbA ( 1c ) from baseline to the end of the study",NR,-0.68 %
0,HbA ( 1c ) from baseline to the end of the study,-0.78 %,NR
